Reacción #2371

ord-d12ed1b9d8ff40f987297e00a881f389

Ecuación de reacción

[BH4-].[Na+]
sodium borohydride
COc1cccc(Oc2c(NS(=O)(=O)c3ccc(C(C)(C)C)cc3)ncnc2OCCOc2ncc(C(C)=O)cn2)c1
N-[6-{2-(5-acetylpyrimidin-2-yloxy)ethoxy}-5-(3-methoxyphenoxy)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide
C1CCOC1
tetrahydrofuran
CC(C)O
isopropyl alcohol
[BH4-].[Na+]
sodium borohydride
COc1cccc(Oc2c(NS(=O)(=O)c3ccc(C(C)(C)C)cc3)ncnc2OCCOc2ncc(C(C)O)cn2)c1
4-tert-butyl-N-[6-{2-(5-(1-hydroxyethyl)pyrimidin-2-yloxy)ethoxy}-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide
Rendimiento 75.3%

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    Temperaturacooling
  2. 2
    Temperaturacooling
  3. 3
    workup.STIRRINGthe mixture is stirred for 30 minutes
  4. 4
    Extracciónextracted with ethyl acetate
  5. 5
    LavadoThe ethyl acetate layer is washed
  6. 6
    Otrodried
  7. 7
    Concentraciónconcentrated to dryness under reduced pressure
  8. 8
    OtroThe residue is purified by silica gel column chromatography (solvent; chloroform/methanol=40:1~20:1)
  9. 9
    Otrorecrystallized from ethyl acetate/n-hexane

Procedimiento

To a mixture of N-[6-{2-(5-acetylpyrimidin-2-yloxy)ethoxy}-5-(3-methoxyphenoxy)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide (756 mg), tetrahydrofuran (10 ml) and isopropyl alcohol (10 ml) is added with stirring sodium borohydride (48 mg) under ice-cooling, and the mixture is stirred for 40 minutes under ice-cooling. To the reaction solution is further added sodium borohydride (14 mg), and the mixture is stirred for 30 minutes. The mixture is diluted with water, and extracted with ethyl acetate. The ethyl acetate layer is washed, dried, and concentrated to dryness under reduced pressure. The residue is purified by silica gel column chromatography (solvent; chloroform/methanol=40:1~20:1), and recrystallized from ethyl acetate/n-hexane to give 4-tert-butyl-N-[6-{2-(5-(1-hydroxyethyl)pyrimidin-2-yloxy)ethoxy}-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide (571 mg) as crystals.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US05728706uspto-grants-1998_03